Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy. 1998

A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
Albert Einstein Cancer Center, Bronx, New York 10461, USA.

A phase I trial of a 24-hour infusion of paclitaxel was conducted to identify the maximum tolerated dose of paclitaxel with granulocyte colony-stimulating factor (G-CSF) in patients with unresectable malignancy previously untreated with chemotherapy. Nineteen patients with metastatic melanoma or non-small cell lung cancer were treated with paclitaxel administered at 250, 300, 400 mg/m2 every 3 weeks. G-CSF, 5 microg/kg was given as a daily subcutaneous injection 24 hours after the completion of the infusion. Dose limiting myelosuppression and peripheral neuropathy was observed at 400 mg/m2 and 350 mg/m2. Paclitaxel can be safely administered as a 24-hour infusion at 300 mg/m2 with G-CSF. Further studies of paclitaxel and G-CSF are recommended to determine a dose-response relationship in sensitive tumors.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
July 2010, Nihon rinsho. Japanese journal of clinical medicine,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
July 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
August 1994, The Journal of dermatology,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
January 1996, Enfermedades infecciosas y microbiologia clinica,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
September 1991, Bone marrow transplantation,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
January 1993, Journal of the National Cancer Institute. Monographs,
A I Einzig, and P H Wiernik, and S Wadler, and J Kaplan, and L T Benson, and L Tentoramano, and V Tan
October 1994, Seminars in oncology,
Copied contents to your clipboard!